0
0
30 words
0
Comments
Tris Pharma announced it has expanded its partnership with Pediatrix receiving exclusive rights to commercialize its ADHD portfolio
You are the first to view
https://www.labiotech.eu/trends-news/tris-and-pediatrix-extend-partnership-for-adhd-portfol/
Create an account or login to join the discussion